COLLPLANT RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSat, 04 Apr 2026 04:59:42 +0200https://images.finanzen.net/images/finanzen_net_neu.gifCOLLPLANT RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netCollplant präsentierte QuartalsergebnisseSat, 28 Mar 2026 06:35:07 +0100https://www.finanzen.net/nachricht/aktien/collplant-praesentierte-quartalsergebnisse-15582121Collplant gab am 26.03.2026 die Zahlen für das am 31.12.2025 abgelaufene Quartal bekannt.Collplant vermeldete für das jüngste Quartal einen Verlust je Aktie von 0,25 USD. Im Vorjahr hatte das Unternehmen ein EPS von ...

]]>https://www.finanzen.net/nachricht/aktien/collplant-praesentierte-quartalsergebnisse-15582121Collplant: So schnitt der Konzern im vergangenen Quartal abFri, 28 Nov 2025 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/collplant-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15319431Collplant hat am 26.11.2025 die Geschäftsergebnisse zum am 30.09.2025 abgelaufenen Quartal offengelegt.Der Verlust je Aktie belief sich auf 0,27 USD. Im Vorjahresquartal hatten -0,380 USD je Aktie in den Büchern gestanden.Redaktion ...

]]>https://www.finanzen.net/nachricht/aktien/collplant-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15319431COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEWed, 26 Nov 2025 13:30:00 +0100https://www.finanzen.net/nachricht/aktien/collplant-biotechnologies-reports-2025-third-quarter-financial-results-and-provides-corporate-update-15314862
  • Expansion of rhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics center scheduled to become operational this ...

    ]]>https://www.finanzen.net/nachricht/aktien/collplant-biotechnologies-reports-2025-third-quarter-financial-results-and-provides-corporate-update-15314862COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTSTue, 18 Nov 2025 13:00:00 +0100https://www.finanzen.net/nachricht/aktien/collplant-biotechnologies-announces-date-for-2025-third-quarter-financial-results-15287490

    REHOVOT, Israel, Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative ...

    ]]>    https://www.finanzen.net/nachricht/aktien/collplant-biotechnologies-announces-date-for-2025-third-quarter-financial-results-15287490    CollPlant Expands its rhCollagen Distribution Capabilities in the United States and CanadaMon, 27 Oct 2025 12:01:00 +0100https://www.finanzen.net/nachricht/aktien/collplant-expands-its-rhcollagen-distribution-capabilities-in-the-united-states-and-canada-15125167

    -- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies --

    REHOVOT, ...

    ]]>    https://www.finanzen.net/nachricht/aktien/collplant-expands-its-rhcollagen-distribution-capabilities-in-the-united-states-and-canada-15125167    CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of TechnologyMon, 20 Oct 2025 13:00:00 +0200https://www.finanzen.net/nachricht/aktien/collplant-s-rhcollagen-based-bioink-demonstrates-strong-performance-compared-to-matrigel-in-study-conducted-by-technion-israel-institute-of-technology-15096654
    • A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel®, a leading extracellular ...

      ]]>https://www.finanzen.net/nachricht/aktien/collplant-s-rhcollagen-based-bioink-demonstrates-strong-performance-compared-to-matrigel-in-study-conducted-by-technion-israel-institute-of-technology-15096654First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInkThu, 16 Oct 2025 13:00:00 +0200https://www.finanzen.net/nachricht/aktien/first-in-kind-fully-humanized-3d-bioprinted-human-skin-model-developed-by-mayo-clinic-researchers-using-collplant-s-rhcollagen-based-bioink-15078536
      • The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research.
      • According to a scientific article published in the Archives of Dermatological ...

        ]]>https://www.finanzen.net/nachricht/aktien/first-in-kind-fully-humanized-3d-bioprinted-human-skin-model-developed-by-mayo-clinic-researchers-using-collplant-s-rhcollagen-based-bioink-15078536